End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.54 CNY | +0.46% |
|
-1.41% | +19.56% |
07-17 | Huahai Pharmaceutical Gets Nod to Register Quetiapine Fumarate Tablets | MT |
07-09 | Zhejiang Huahai Pharmaceutical Subsidiaries Get Regulatory Nod for Tumor Clinical Trial; Shares Down 3% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.56% | 3.5B | |
+55.35% | 815B | |
+32.33% | 597B | |
-0.10% | 377B | |
+15.47% | 319B | |
+13.10% | 310B | |
+16.21% | 247B | |
+14.25% | 228B | |
+16.54% | 180B | |
+4.31% | 170B |
- Stock Market
- Equities
- 600521 Stock
- News Zhejiang Huahai Pharmaceutical Co., Ltd.
- Huahai Pharmaceutical Gets Nod to Register Quetiapine Fumarate Tablets